ExADIPO²™ Peptourbillon™ 18mg (Tirzepatide + Selank Dual-Layer)

ExADIPO²™ Peptourbillon™ – 18 mg Tirzepatide + Selank (Lyoprester Cartridge + EZnject Kit)

ExADIPO²™ IDENTITY

Type: Dual-layer
Half-life: Tirzepatide ≈ 120 hours, Selank ≈ 24 minutes

ExADIPO²™ Peptourbillon represents our advanced dual-layer Peptourbillon™ formulation, containing a precision-engineered combination of 16 mg highly purified Tirzepatide (dual GIP/GLP-1 receptor agonist, Mounjaro, CAS 2023788-19-2, MW 4813.50 Da) and 2 mg premium-grade Selank (anxiolytic nootropic, Selanc, CAS 129954-34-3, MW 751.87 Da). Furthermore, this ExADIPO²™ Peptourbillon creates an advanced metabolic and cognitive enhancement research complex. Additionally, the innovative dual-layer Peptourbillon™ technology leverages synergistic incretin and GABAergic mechanisms for comprehensive physiological research applications.

Why Choose ExADIPO²™ Peptourbillon?

Moreover, this synergistic dual-peptide formulation combines Tirzepatide’s superior dual incretin receptor agonism with Selank’s anxiolytic and cognitive enhancement properties. Additionally, research-grade purity levels (≥99.1%) provide exceptional receptor selectivity and minimal cross-reactivity. Furthermore, the advanced dual-layer Peptourbillon™ technology ensures optimal stability and sequential release profiles. Consequently, the precision EZnject™ micro-indexed dosing system delivers 100 accurate doses with consistent bioavailability. Moreover, comprehensive analytical validation across five platforms confirms superior quality and reproducible research outcomes.

WHAT’S IN THE EZNJECT™ KIT:

• 1 × Lyoprester® dual-chamber cartridge (auto-reconstitution): 18 mg total peptide blend (16 mg Tirzepatide + 2 mg Selank) (argon-flushed, vacuum-sealed) + 1 mL P-EARL™ (Panacea-Engineered Aseptic Reconstitution Liquid)
• 1 × EZnject™ disposable auto-injector pen (100 micro-indexed doses)
• 4 × 31 G / 5 mm painless needles
• 5 × sterile alcohol prep swabs (one dedicated for the Lyoprester septa needle cushion)
• Quick-start guide printed on box with QR code linking to instructional video
• NFC-enabled quick-start tag linking to expiry counter and batch information

ANALYTICAL DATA:

• Purity: ≥99.1% (validated by Agilent 1260 Infinity II RP-HPLC)
• Molecular Weight: 4813.50 Da / 751.87 Da (confirmed by Thermo Fisher Q Exactive Plus Orbitrap ESI-MS)
• Binding Affinity: KD 0.8 nM (GLP-1R), 0.64 nM (GIPR) (validated by Luminex MagPix multiplex assays)
• Functional cAMP Assay: EC50 0.4 nM (Applied Biosystems QuantStudio 6 & 7, StepOnePlus qPCR)
• Gene Expression Analysis: Affymetrix GeneChip Human Gene 2.0 ST confirms minimal off-target effects (Δlog2 < 0.15 across 60,000+ probes)

PEPTIDE COMPONENT ANALYSIS:

Tirzepatide (dual GIP/GLP-1 receptor agonist, Mounjaro):

• Purity: ≥99.1% (validated by Agilent 1260 Infinity II RP-HPLC)
• Molecular Weight: 4813.50 Da (confirmed by Thermo Fisher Q Exactive Plus Orbitrap)
• CAS Number: 2023788-19-2
• Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys(C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
• Receptor Binding Affinity: KD 0.8 nM (GLP-1R), 0.64 nM (GIPR) (validated by Luminex MagPix multiplex binding assays)
• Functional Activity: EC50 0.4 nM (Applied Biosystems QuantStudio platform with CHO-K1 cells)
• Off-target Analysis: Affymetrix GeneChip Human Gene 2.0 ST – no significant differential expression (Δlog2 < 0.15)

Selank (anxiolytic nootropic, Selanc):

• Purity: ≥99.4% (validated by Agilent 1260 Infinity II RP-HPLC)
• Molecular Weight: 751.87 Da (confirmed by Thermo Fisher Q Exactive Plus Orbitrap)
• CAS Number: 129954-34-3
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• Receptor Binding Affinity: GABAergic modulation (validated by Luminex MagPix GABA receptor binding assays)
• Functional Activity: Anxiolytic EC50 1.8 nM (Applied Biosystems QuantStudio platform with neuronal cultures)
• Off-target Analysis: Affymetrix GeneChip Human Gene 2.0 ST – selective GABAergic effects (Δlog2 < 0.1)

STORAGE & STABILITY:

Unprimed Lyoprester® cartridges maintain stability at room temperature. Additionally, primed cartridges remain stable for 40 days at 3°C. Furthermore, protect from direct light exposure. Keep out of sight and reach of children.

INTENDED USE:

Strictly for in-vitro or in-vivo laboratory research only. Purchasing this product confirms professional research intent and compliance with institutional research protocols.